Stealth BioTherapeutics Corp - ADR

0.00 (+0.90%)
Mergers / Acquisitions

Stealth Biotherapeutics Corp Enters Definitive Agreement For Going Private Transaction

Published: 08/01/2022 13:36 GMT
Stealth BioTherapeutics Corp - ADR (MITO) - Stealth Biotherapeutics Corp Enters Definitive Agreement for Going Private Transaction.
Stealth Biotherapeutics Corp - Entered Into a Definitive Agreement and Plan of Merger With Stealth Parent Limited.
Stealth Biotherapeutics Corp - Consortium Intends to Fund Merger Through Cash Contributions From Members of Consortium.
Stealth Biotherapeutics Corp - Special Committee Negotiated Terms of Merger Agreement With Assistance of Its Independent Financial and Legal Advisors.
Stealth Biotherapeutics - If Completed, Merger Will Result in Co Becoming a Privately-held Company and Its Adss Will No Longer Be Listed on Nasdaq.
Stealth Biotherapeutics - to Be Acquired by Consortium of Investors Led by Morningside Venture and J. Wood Capital Advisors in All-cash Transaction.
Stealth Biotherapeutics- Each Ordinary Share to Be Cancelled and Cease to Exist, in Exchange for Right to Receive Us$0.03125 in Cash Without Interest.
Stealth Biotherapeutics - Each Outstanding American Depositary Share to Be Cancelled in Exchange for Right to Get Us$0.375 in Cash Without Interest.